Phenotypic analysis of images of zebrafish treated with Alzheimer's γ-secretase inhibitors

BACKGROUND: Several γ-secretase inhibitors (GSI) are in clinical trials for the treatment of Alzheimer's disease (AD). This enzyme mediates the proteolytic cleavage of amyloid precursor protein (APP) to generate amyloid β protein, Aβ, the pathogenic protein in AD. The γ-secretase also cleaves N...

Descripción completa

Detalles Bibliográficos
Autores principales: Arslanova, Dilyara, Yang, Ting, Xu, Xiaoyin, Wong, Stephen T, Augelli-Szafran, Corinne E, Xia, Weiming
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851663/
https://www.ncbi.nlm.nih.gov/pubmed/20307292
http://dx.doi.org/10.1186/1472-6750-10-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851663/
https://www.ncbi.nlm.nih.gov/pubmed/20307292
http://dx.doi.org/10.1186/1472-6750-10-24

Ejemplares similares